GDOC vs. CNCR
Compare and contrast key facts about Goldman Sachs Future Health Care Equity ETF (GDOC) and Loncar Cancer Immunotherapy ETF (CNCR).
GDOC and CNCR are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GDOC is an actively managed fund by Goldman Sachs. It was launched on Nov 9, 2021. CNCR is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Loncar Cancer Immunotherapy Index. It was launched on Oct 13, 2015.
Performance
GDOC vs. CNCR - Performance Comparison
Loading graphics...
GDOC vs. CNCR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
GDOC Goldman Sachs Future Health Care Equity ETF | -5.22% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
Returns By Period
GDOC
- 1D
- 2.76%
- 1M
- -5.94%
- YTD
- -8.12%
- 6M
- 2.88%
- 1Y
- 1.53%
- 3Y*
- 0.66%
- 5Y*
- —
- 10Y*
- —
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GDOC vs. CNCR - Expense Ratio Comparison
GDOC has a 0.75% expense ratio, which is lower than CNCR's 0.79% expense ratio.
Return for Risk
GDOC vs. CNCR — Risk / Return Rank
GDOC
CNCR
GDOC vs. CNCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Goldman Sachs Future Health Care Equity ETF (GDOC) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GDOC | CNCR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.08 | — | — |
Sortino ratioReturn per unit of downside risk | 0.25 | — | — |
Omega ratioGain probability vs. loss probability | 1.03 | — | — |
Calmar ratioReturn relative to maximum drawdown | 0.10 | — | — |
Martin ratioReturn relative to average drawdown | 0.31 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GDOC | CNCR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.08 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.20 | — | — |
Dividends
GDOC vs. CNCR - Dividend Comparison
GDOC's dividend yield for the trailing twelve months is around 0.35%, while CNCR has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GDOC Goldman Sachs Future Health Care Equity ETF | 0.35% | 0.32% | 0.02% | 0.55% | 0.00% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GDOC vs. CNCR - Drawdown Comparison
The maximum GDOC drawdown since its inception was -31.01%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for GDOC and CNCR.
Loading graphics...
Drawdown Indicators
| GDOC | CNCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -31.01% | 0.00% | -31.01% |
Max Drawdown (1Y)Largest decline over 1 year | -14.57% | — | — |
Current DrawdownCurrent decline from peak | -15.86% | 0.00% | -15.86% |
Average DrawdownAverage peak-to-trough decline | -15.90% | 0.00% | -15.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.96% | — | — |
Volatility
GDOC vs. CNCR - Volatility Comparison
Loading graphics...
Volatility by Period
| GDOC | CNCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.04% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 11.22% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.63% | 0.00% | +18.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.83% | 0.00% | +18.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.83% | 0.00% | +18.83% |